Galecto Biotech (private company)

See something wrong or missing? Let us know
Offices:
Copenhagen
Business model:
B2B
Investors:
we tracked 5 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 3 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis, cancer and inflammation

Companies with similar profile to Galecto Biotech:

CompanyCriteria
Denmark NMD Pharma
66%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Forendo Pharma
65%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • At least one other investor: Merck Ventures
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden AMRA
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden OxThera
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Acarix
55%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners, Sunstone Capital, SEED Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Denmark Orphazyme
55%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden ITBMed
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Norway Oncoinvent
54%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Merozyne Therapeutics
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark Antag
46%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
Denmark BioPhero
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Minim one investor from outside Scandinavia: Yes
Denmark Biosyntia
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Minim one investor from outside Scandinavia: Yes
Denmark Acesion Pharma
45%
  • Similar verticals: Biotech
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Minim one investor from outside Scandinavia: Yes
Denmark Vivino
44%
  • Similar business models: B2B
  • At least one vc investor: SEED Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden Flatfrog
44%
  • Similar business models: B2B
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Sweden BoneSupport
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Natural Cycles
44%
  • Similar verticals: Health services
  • At least one vc investor: Sunstone Capital
  • Total raised in a similar range: 10M+ USD
  • Minim one investor from outside Scandinavia: Yes
Finland Optomed
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes
Finland TILT Biotherapeutics
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Chundsell Medicals
44%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Minim one investor from outside Scandinavia: Yes